{"ORPHApacket":[{"ORPHApacketID":"206575","date":"2019-12-06 00:04:04","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"206575","Name":[{"lang":"en","label":"Rippling muscle disease with myasthenia gravis"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_206575","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Immune-mediated acquired neuromuscular junction disease"}],"ORPHA":"464764","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_464764"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Rippling muscle disease with myasthenia gravis is a rare, acquired, neuromuscular disease characterized by <i>CAV3<\/i> mutation-negative rippling muscle disease in association with acetylcholine receptor antibody-mediated myasthenia gravis. Patients typically present exercise-induced, electrically-silent muscle rippling with myalgia, in combination with generalized myasthenia gravis symptoms (ptosis, diplopia, neck weakness, dysphagia and dyspnea)."}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Not applicable"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"Acquired rippling muscle disease"},{"lang":"en","label":"Immune-mediated rippling muscle disease"}]}]}]}